Emergent BioSolutions to Webcast Presentation at Bank of America Merrill Lynch 2013 Health Care Conf
Emergent BioSolutions to Webcast Presentation at Bank of America Merrill Lynch 2013 Health Care Conference
ROCKVILLE, Md.--(BUSINESS WIRE)-- Emergent BioSolutions Inc. (NYS: EBS) announced today that the company will be webcasting its presentation at the Bank of America Merrill Lynch 2013 Health Care Conference in Las Vegas on May 16, 2013 at 10:40 AM Pacific. During the presentation, a member of the company's management team will provide a corporate overview, which may include a discussion of the company's recent business developments as well as its current financial results and financial guidance for the current year and latest quarterly period. The webcast of this presentation will be available both live and by replay, accessible from the Emergent website www.emergentbiosolutions.com under "Investors."
About Emergent BioSolutions Inc.
Emergent BioSolutions is a specialty pharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Additional information about us may be found at www.emergentbiosolutions.com.
Follow us on twitter: @emergentbiosolu.
Emergent BioSolutions Inc.
Investors Contact:
Robert G. Burrows
Vice President, Investor Relations
301-795-1877
BurrowsR@ebsi.com
or
Media Contact:
Tracey Schmitt
Vice President, Corporate Communications
301-795-1800
SchmittT@ebsi.com
KEYWORDS: United States North America Maryland Nevada
INDUSTRY KEYWORDS:
The article Emergent BioSolutions to Webcast Presentation at Bank of America Merrill Lynch 2013 Health Care Conference originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
